Katrina L Scarff

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Decision Making

Contrast Enhanced Ultrasound

Gene Expression

Top Venues

Prenatal diagnosis

This page only lists publications with an associated author ORCID identifier.

Publications

Katrina L Scarff, Nicola Flowers, Clare J Love, Alison D Archibald, Clare E Hunt, Olivia Giouzeppos, Justine Elliott, Martin B Delatycki, Mark Domenic Pertile
Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening. Prenatal diagnosis 43 (2) (2023)
Katrina L Scarff, Nicola Flowers, Clare J Love, Alison D Archibald, Clare E Hunt, Olivia Giouzeppos, Justine Elliott, Martin B Delatycki, Mark Domenic Pertile
Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening. Prenatal diagnosis 43 (2) (2023)
Katrina L Scarff, Nicola Flowers, Clare J Love, Alison D Archibald, Clare E Hunt, Olivia Giouzeppos, Justine Elliott, Martin B Delatycki, Mark Domenic Pertile
Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening. Prenatal diagnosis (2023)
Katrina L Scarff, Nicola Flowers, Clare J Love, Alison D Archibald, Clare E Hunt, Olivia Giouzeppos, Justine Elliott, Martin B Delatycki, Mark Domenic Pertile
Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening. Prenatal diagnosis 43 (2) (2023)
Katrina L Scarff, Nicola Flowers, Clare J Love, Alison D Archibald, Clare E Hunt, Olivia Giouzeppos, Justine Elliott, Martin B Delatycki, Mark Domenic Pertile
Performance of a cfDNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cfDNA screening. Prenatal diagnosis (2023)